© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Payal Kohli, MD
Articles
Efficacy, Safety of Edoxaban by AF Subtype: An Analysis From ENGAGE AF-TIMI 48
July 09, 2014
Post hoc analysis of the ENGAGE AF-TIMI 48 study looked at safety and efficacy of a novel oral anticoagulant in distinct groups with paroxysmal, persistent, or permanent atrial fibrillation.
Ablation for Atrial Flutter: Treats the Arrhythmia but Not the Stroke Risk
July 08, 2014
A new study finds that ablation for atrial flutter reduces hospital-based costs, symptoms, and risk of atrial fibrillation. For stroke risk? Continue anticoagulation.
Vegetarian Diet Reduces BP, Study Finds
June 28, 2014
Lower blood pressure may be one dividend of an all-vegetarian diet, according to a recent meta-analysis.
Bisphosphonates Increase Risk of Incident AF
June 11, 2014
A meta-analysis shows both IV and oral formulations pose a risk of arrhythmia, the former more so than the latter. But these are very effective drugs. What next?
Cryptogenic Stroke: Is Occult Arrhythmia a Factor?
June 11, 2014
Results from the CRYSTAL-AF study find that nearly one-third of patients who experience cryptogenic stroke may have undetected atrial fibrillation.
The Death of "Lone Atrial Fibrillation"
June 10, 2014
A recent white paper declares it time to abolish the ambiguous term. Given current knowledge of atrial fibrillation, the 60-year-old description serves only to confuse.
Abdominal Aortic Aneurysm: Screen Older Male Smokers, Says USPSTF
May 21, 2014
The United States Preventive Services Task Force narrows recommendations for populations that warrant screening. Guideline revisions are based on a new evidence review.
What Regimen to Minimize Thromboembolic Risk and Bleeding?
May 09, 2014
Aging baby boomers will more frequently appear in primary care offices with cardiovascular diseases that place them at high risk for both clotting and bleeding. Many will also have atrial fibrillation. Is there a sure-fire therapeutic formula for all?
Apixaban Comparable to Warfarin After Cardioversion for Atrial Fibrillation
May 09, 2014
In a clinical trial setting, performance of the new oral anticoagulant and the long-time gold standard was similar. In the real world, where adherence can be a problem, there is a risk/benefit ratio to consider.
Uninterrupted Warfarin During Atrial Fibrillation Ablation Decreases Stroke Risk
May 07, 2014
Warfarin continued in the periprocedural period yielded lower rates of stroke, TIA, and minor bleeding than use of heparin to bridge catheter ablation surgery for AF.